[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI961105A - Analogs against difluorostatonin virus - Google Patents

Analogs against difluorostatonin virus Download PDF

Info

Publication number
FI961105A
FI961105A FI961105A FI961105A FI961105A FI 961105 A FI961105 A FI 961105A FI 961105 A FI961105 A FI 961105A FI 961105 A FI961105 A FI 961105A FI 961105 A FI961105 A FI 961105A
Authority
FI
Finland
Prior art keywords
difluorostatonin
virus
analogs against
analogs
antiviral
Prior art date
Application number
FI961105A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI961105A0 (en
Inventor
Dorsselaer Viviane Van
Daniel Schirlin
Celine Tarnus
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI961105A0 publication Critical patent/FI961105A0/en
Publication of FI961105A publication Critical patent/FI961105A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)

Abstract

This invention relates to novel statone antiviral analogs, to the processes and intermediates useful for their preparation and to their use as antiviral agents.
FI961105A 1993-09-09 1996-03-08 Analogs against difluorostatonin virus FI961105A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93402194 1993-09-09
PCT/US1994/009053 WO1995007257A1 (en) 1993-09-09 1994-08-10 Difluoro statone antiviral analogs

Publications (2)

Publication Number Publication Date
FI961105A0 FI961105A0 (en) 1996-03-08
FI961105A true FI961105A (en) 1996-03-08

Family

ID=8214747

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961105A FI961105A (en) 1993-09-09 1996-03-08 Analogs against difluorostatonin virus

Country Status (20)

Country Link
US (2) US5831094A (en)
EP (1) EP0717731B1 (en)
JP (1) JPH09502437A (en)
KR (1) KR100308839B1 (en)
CN (1) CN1130898A (en)
AT (1) ATE179167T1 (en)
AU (1) AU683927B2 (en)
CA (1) CA2170607C (en)
DE (1) DE69418050T2 (en)
DK (1) DK0717731T3 (en)
ES (1) ES2133573T3 (en)
FI (1) FI961105A (en)
GR (1) GR3030352T3 (en)
HU (1) HUT74569A (en)
IL (1) IL110865A (en)
NO (1) NO960849D0 (en)
NZ (1) NZ271825A (en)
TW (1) TW282449B (en)
WO (1) WO1995007257A1 (en)
ZA (1) ZA946815B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU702487B2 (en) * 1995-08-30 1999-02-25 G.D. Searle & Co. Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
WO2000044770A1 (en) * 1999-01-28 2000-08-03 Chugai Seiyaku Kabushiki Kaisha Substituted phenethylamine derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066643A (en) * 1985-02-19 1991-11-19 Sandoz Ltd. Fluorine and chlorine statine or statone containing peptides and method of use
CH672792A5 (en) * 1985-02-19 1989-12-29 Sandoz Ag
EP0218688B1 (en) * 1985-04-19 1990-09-12 The Upjohn Company Dihalo-statine substituted renin inhibitors
GB8619182D0 (en) * 1986-08-06 1986-09-17 Sandoz Ltd Peptides & derivatives
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
FR2614533A1 (en) * 1987-04-23 1988-11-04 Sandoz Sa NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
GB2212158A (en) * 1987-12-15 1989-07-19 Sandoz Ltd Trialkylsilymethyl-substituted peptides; renin inhibitors
IL90872A0 (en) * 1988-07-08 1990-02-09 Smithkline Beckman Corp Retroviral protease binding peptides
AU3964489A (en) * 1988-07-08 1990-02-05 Smithkline Beckman Corporation Retroviral protease binding peptides
CA2010531A1 (en) * 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
US5151438A (en) * 1989-05-23 1992-09-29 Abbott Laboratories Retroviral protease inhibiting compounds
KR100220876B1 (en) * 1991-01-02 1999-10-01 슈테펜엘.네스비트 Anti-viral compounds
EP0565631B1 (en) * 1991-01-02 1996-09-18 Merrell Pharmaceuticals Inc. Anti-viral compounds
HU9402744D0 (en) * 1992-03-25 1994-12-28 Pfizer Ltd Antiviral peptides
GB9210744D0 (en) * 1992-05-20 1992-07-08 Pfizer Ltd Antiviral peptides
DK0641325T3 (en) * 1992-05-21 2001-04-17 Monsanto Co Inhibitors of retroviral protease
NZ268202A (en) * 1993-07-08 1997-09-22 Merrell Pharma Inc 2,2-difluoro-4-aminobutanoic acid amide and 2,2-difluoro-5,7-diazaoctan-1,8-dioic acid-1-amide derivatives (statone analogues); pharmaceutical compositions
WO1996002499A1 (en) * 1994-07-15 1996-02-01 Merrell Pharmaceuticals Inc. Difluorostatone antiviral agents

Also Published As

Publication number Publication date
CA2170607A1 (en) 1995-03-16
AU7560694A (en) 1995-03-27
NZ271825A (en) 1997-11-24
JPH09502437A (en) 1997-03-11
EP0717731A1 (en) 1996-06-26
FI961105A0 (en) 1996-03-08
IL110865A0 (en) 1994-11-28
KR100308839B1 (en) 2002-10-04
NO960849L (en) 1996-03-01
US5831094A (en) 1998-11-03
DK0717731T3 (en) 1999-11-01
ES2133573T3 (en) 1999-09-16
HUT74569A (en) 1997-01-28
HU9600601D0 (en) 1996-05-28
KR960704838A (en) 1996-10-09
TW282449B (en) 1996-08-01
NO960849D0 (en) 1996-03-01
ATE179167T1 (en) 1999-05-15
GR3030352T3 (en) 1999-09-30
US5948778A (en) 1999-09-07
AU683927B2 (en) 1997-11-27
IL110865A (en) 1999-07-14
CA2170607C (en) 2000-02-22
EP0717731B1 (en) 1999-04-21
DE69418050T2 (en) 1999-11-25
CN1130898A (en) 1996-09-11
ZA946815B (en) 1995-04-24
WO1995007257A1 (en) 1995-03-16
DE69418050D1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
DE69333109D1 (en) THERAPEUTIC NUCLEOSIDES
ID23374A (en) HALOGENOPIRIMIDIN
ES2191292T3 (en) POLYAROMATIC ANTIVIRAL COMPOUNDS.
KR960702830A (en) N-Alkylthio polyaine derivatives as radioprotective agents
FI932997A0 (en) ANTIVIRAL FOERENINGAR
SE9604582D0 (en) Novel compounds
FI961105A (en) Analogs against difluorostatonin virus
DK0720597T3 (en) Triarylethylene derivatives for therapeutic use
NO960048D0 (en) Difluorstaton analogs
CA2249786A1 (en) Difluoro statone analogs

Legal Events

Date Code Title Description
MA Patent expired